Millbrae, CA, United States of America

Yongmei Chen

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 6.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • San Francisco, CA (US) (2014 - 2016)
  • Millbrae, CA (US) (2014 - 2018)
  • South San Francisco, CA (US) (2018 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Yongmei Chen

Introduction

Yongmei Chen is a prominent inventor based in Millbrae, CA (US), known for her significant contributions to the field of biotechnology. With a total of 9 patents to her name, she has made remarkable advancements in the development of bispecific antibodies.

Latest Patents

Among her latest patents, Yongmei Chen has developed a host cell comprising nucleic acids encoding bispecific antibodies that bind to beta-klotho and fibroblast growth factor receptor 1. This innovative subject matter provides antibodies that bind to KLB and FGFR1, along with methods of utilizing these antibodies. In certain embodiments, her bispecific antibody binds to an epitope present on FGFR1 while also binding to an epitope present on KLB. Another notable patent includes nucleic acids encoding bispecific antibodies that serve the same purpose, further showcasing her expertise in this area.

Career Highlights

Yongmei Chen is currently employed at Genentech, Inc., where she continues to push the boundaries of scientific research and innovation. Her work has been instrumental in advancing therapeutic options in the biotechnology sector.

Collaborations

Yongmei has collaborated with notable colleagues such as Yan Wu and Scott Stawicki, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yongmei Chen's contributions to biotechnology through her patents and collaborations highlight her as a leading inventor in her field. Her work continues to impact the development of new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…